Clinical Trial

A Study of SCTB35 in Patients with Systemic Lupus Erythematosus

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This study is a multicenter Phase Ib/II clinical trial aimed at evaluating the safety, tolerability and efficacy of SCTB35 in patients with systemic lupus erythematosus (SLE).
Trial Details
NCT Number NCT06841042
Lead Sponsor Sinocelltech Ltd.
Conditions System Lupus Erythematosus
Enrollment 168 participants
Start Date 2025-02
Primary Completion 2027-05 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2025-02-21